Financhill
Buy
58

ELTP Quote, Financials, Valuation and Earnings

Last price:
$0.56
Seasonality move :
60.74%
Day range:
$0.55 - $0.56
52-week range:
$0.12 - $0.75
Dividend yield:
0%
P/E ratio:
17.32x
P/S ratio:
8.27x
P/B ratio:
12.66x
Volume:
1.7M
Avg. volume:
1.9M
1-year change:
305.8%
Market cap:
$598.2M
Revenue:
$56.6M
EPS (TTM):
-$0.01

Earnings Data

Next earnings date for ELTP
Feb 14
2025
Most recent earnings per share
-$0.01
Missed by $0.01
(Nov 14/2024)
Consensus Estimate
--
(Nov 14/2024)

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

ELTP Quarterly Earnings History

Date Quarter Revenue Forecast Actual Revenue Reported EPS Consensus EPS Beat/Miss
11/14/2024 Q3 -- $18.9M -$0.01 -- --
08/14/2024 Q2 -- $18.8M $0.00 -- --
03/31/2024 Q1 -- $17.9M -- -- --
02/15/2024 Q4 -- $15.5M $0.00 -- --
11/14/2023 Q3 -- -- $0.01 -- --
06/30/2023 Q2 -- -- $0.00 -- --
03/31/2023 Q1 -- -- -$0.00 -- --
12/31/2022 Q4 -- -- $0.00 -- --
09/30/2022 Q3 -- -- $0.00 -- --
06/30/2022 Q2 -- -- $0.00 -- --
03/31/2022 Q1 -- -- -- -- --
12/31/2021 Q4 -- -- $0.00 -- --
09/30/2021 Q3 -- -- $0.00 -- --
06/30/2021 Q2 -- -- $0.00 -- --
03/31/2021 Q1 -- -- -- -- --
12/31/2020 Q4 -- -- $0.00 -- --
09/30/2020 Q3 -- -- $0.00 -- --
06/30/2020 Q2 -- -- $0.00 -- --
03/31/2020 Q1 -- -- $0.00 -- --
12/31/2019 Q4 -- -- -$0.00 -- --
09/30/2019 Q3 -- -- -$0.00 -- --
06/30/2019 Q2 -- -- $0.00 -- --
03/31/2019 Q1 -- -- -- -- --
12/31/2018 Q4 -- -- -$0.00 -- --
09/30/2018 Q3 -- -- -$0.00 -- --
06/30/2018 Q2 -- -- -$0.00 -- --
03/31/2018 Q1 -- -- -$0.00 -- --
12/31/2017 Q4 -- -- -$0.00 -- --
09/30/2017 Q3 -- -- $0.00 -- --
06/30/2017 Q2 -- -- -$0.00 -- --
03/31/2017 Q1 -- -- -$0.01 -- --
12/31/2016 Q4 -- -- $0.00 -- --
09/30/2016 Q3 -- -- -$0.00 -- --
06/30/2016 Q2 -- -- -$0.00 -- --
03/31/2016 Q1 -- -- $0.04 -- --
12/31/2015 Q4 -- -- -$0.05 -- --
09/30/2015 Q3 -- -- -$0.01 -- --
06/30/2015 Q2 -- -- -$0.00 -- --
03/31/2015 Q1 -- -- -$0.02 -- --
12/31/2014 Q4 -- -- -$0.01 -- --

Elite Pharmaceuticals Earnings Questions

  • How Much did Elite Pharmaceuticals Generate in Revenue Last Quarter?

    Elite Pharmaceuticals reported $18.9M worth of top line sales in its most recent quarter.

  • Did Elite Pharmaceuticals Beat Earnings Last Quarter?

    Elite Pharmaceuticals announced earnings per share of -$0.01 which represents a miss of analyst forecast a -- per share.

  • Is Elite Pharmaceuticals Profitable?

    Elite Pharmaceuticals reported $8.2M that represents $0.01 per share over the last quarter.

  • What is the Analyst Consensus for Elite Pharmaceuticals EPS Next Year?

    Elite Pharmaceuticals's earnings are forecast to grow from $0.02 per share to -- per share next year representing an increase of --.

  • When is Elite Pharmaceuticals's Earnings Date?

    Elite Pharmaceuticals's next earnings date is February 14, 2025.

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

Popular

Is Uber Stock a Buy on the Dip?
Is Uber Stock a Buy on the Dip?

Shares of Uber Technologies (NYSE:UBER) have been fading fast in…

Is AMD Stock an All-Time Buy?
Is AMD Stock an All-Time Buy?

Advanced Micro Devices (NASDAQ:AMD) is a high-growth AI stock that…

How High Will Airbnb Stock Go?
How High Will Airbnb Stock Go?

Airbnb, Inc. (NASDAQ:ABNB) share price has seen substantial turbulence over…

Stock Ideas

Buy
65
Is AAPL Stock a Buy?

Market Cap: $3.9T
P/E Ratio: 43x

Buy
56
Is NVDA Stock a Buy?

Market Cap: $3.4T
P/E Ratio: 117x

Buy
57
Is MSFT Stock a Buy?

Market Cap: $3.3T
P/E Ratio: 37x

Alerts

Buy
64
ARQQ alert for Dec 27

Arqit Quantum [ARQQ] is down 3.22% over the past day.

Buy
64
QMCO alert for Dec 27

Quantum [QMCO] is up 4.72% over the past day.

Buy
65
ALGS alert for Dec 27

Aligos Therapeutics [ALGS] is down 4.82% over the past day.

THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS

Show me the best stock